© 1994 Oxford University Press
OTHER |
Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas
Neurogenetics Laboratory and Division of Neurology, Cedars-Sinai Medical Center, University of California at Los Angeles 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
*To whom correspondence should be addressed
Received January 13, 1994; Revised April 11, 1994; Accepted April 11, 1994
Schwannomas are common tumors of the nervous system and are frequently found in patients with neurofibromatosis (NF) 2. Although loss of heterozygosity in NF2 tumors suggests that the NF2 gene functions as a tumor suppressor gene, the NF2 gene shows amino acid sequence homology to structural proteins in one of which dominantly acting mutations have been described. We performed a mutational analysis in 30 vestibular schwannomas and examined the effect of mutations on the NF2 protein. We detected 18 mutations in 30 vestibular schwannomas of which seven contained loss or mutation of both NF2 alleles. Most mutations were predicted to result in a truncated protein. Mutational hot spots were not identified. Immunocytochemical studies using antibodies to the NF2 protein showed complete absence of staining in tumor Schwann cells, whereas staining was observed in normal vestibular nerve. These data indicate that loss of NF2 protein function is a necessary step in schwannoma pathogenesis and that the NF2 gene functions as a recessive tumor suppressor gene.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. R. Scoles, W. H. Yong, Y. Qin, K. Wawrowsky, and S. M. Pulst Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c) Hum. Mol. Genet., April 1, 2006; 15(7): 1059 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M E Baser and T Y Poussaint Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma J. Med. Genet., March 1, 2006; 43(3): 285 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M E Baser, L Kuramoto, R Woods, H Joe, J M Friedman, A J Wallace, R T Ramsden, S Olschwang, E Bijlsma, M Kalamarides, et al. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 J. Med. Genet., July 1, 2005; 42(7): 540 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rangwala, F. Banine, J.-P. Borg, and L. S. Sherman Erbin Regulates Mitogen-activated Protein (MAP) Kinase Activation and MAP Kinase-dependent Interactions between Merlin and Adherens Junction Protein Complexes in Schwann Cells J. Biol. Chem., March 25, 2005; 280(12): 11790 - 11797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gonzalez-Gomez, M. J. Bello, M. E. Alonso, J. Lomas, D. Arjona, J. M. d. Campos, J. Vaquero, A. Isla, L. Lassaletta, M. Gutierrez, et al. CpG Island Methylation in Sporadic and Neurofibromatis Type 2-Associated Schwannomas Clin. Cancer Res., November 15, 2003; 9(15): 5601 - 5606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-X. Sun, C. Haipek, D. R. Scoles, S. M. Pulst, M. Giovannini, M. Komada, and D. H. Gutmann Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet., December 1, 2002; 11(25): 3167 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Scoles, V. D. Nguyen, Y. Qin, C.-X. Sun, H. Morrison, D. H. Gutmann, and S.-M. Pulst Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling Hum. Mol. Genet., December 1, 2002; 11(25): 3179 - 3189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kressel and B. Schmucker Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15 Hum. Mol. Genet., September 15, 2002; 11(19): 2269 - 2278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Scoles, D. P. Huynh, M. S. Chen, S. P. Burke, D. H. Gutmann, and S.-M. Pulst The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet., July 1, 2000; 9(11): 1567 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Goutebroze, E. Brault, C. Muchardt, J. Camonis, and G. Thomas Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins Mol. Cell. Biol., March 1, 2000; 20(5): 1699 - 1712. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. den Bakker, K. J. Vissers, A. C. Molijn, J. M. Kros, E. C. Zwarthoff, and T. H. van der Kwast Expression of the Neurofibromatosis Type 2 Gene in Human Tissues J. Histochem. Cytochem., November 1, 1999; 47(11): 1471 - 1480. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Giovannini, E. Robanus-Maandag, M. Niwa-Kawakita, M. van der Valk, J. M. Woodruff, L. Goutebroze, P. Mérel, A. Berns, and G. Thomas Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein Genes & Dev., April 15, 1999; 13(8): 978 - 986. [Abstract] [Full Text]
|
|
|
|
 |
|
 M Sainio, F Zhao, L Heiska, O Turunen, M den Bakker, E Zwarthoff, M Lutchman, G. Rouleau, J Jaaskelainen, A Vaheri, et al. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton J. Cell Sci., January 9, 1997; 110(18): 2249 - 2260. [Abstract] [PDF]
|
|